| Name | Title | Contact Details |
|---|
PL Developments is a Westbury, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
To be the Best Community Healthcare System in New England. About Rutland Regional Medical Center The biggest community hospital in Vermont and the second largest hospital in the state, Rutland Regional Medical Center has been providing high quality healthcare to the Rutland Region for more than 100 years. As the needs of our community have grown and changed, so has Rutland Regional, adding services, staff and facilities. Today, Rutland Regional Medical Center is a 144 bed hospital, employing over 1,600 professional and support staff including 227 providers trained in 36 specialty areas. Providing preventive, diagnostic, acute and rehabilitative services, Rutland Regional Medical Center serves Rutland County, portions of southern and central Vermont and communities in eastern New York State. The hospital`s medical staff is supported by excellent nurses, high quality diagnostic and ancillary services and a broad array of sophisticated equipment technology, including advanced diagnostic imaging, a top-of-the-line linear accelerator used in the treatment of cancer patients, and a diagnostic Cardiovascular and Angiographic Lab. At Rutland Regional we manage and adapt to change and growth while continuing our focus on a high standard of personalized, quality medical care, adding key specialties to serve community needs, and focusing on attracting and recruiting highly trained doctors, nurses and staff. We are committed to providing the services, both in and out of the hospital, required to maintain the health of not just our patients, but the entire community
The Mason City Clinic was formed on January 1, 1989, with the merger of three physician groups -- Surgical Associates, Internal Medicine Associates and Independent Medical Surgical Group.
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.
The Arc of Anchorage is a Anchorage, AK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.